Supernus Pharmaceuticals, Inc. (SUPN)
53.30
+2.61
(+5.15%)
USD |
NASDAQ |
Feb 24, 16:00
55.00
+1.70
(+3.19%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Liabilities (Quarterly) : 370.09M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Oncotelic Therapeutics, Inc. | 20.08M |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Krystal Biotech, Inc. | 114.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.420B |
| Shareholders Equity (Quarterly) | 1.050B |
| Debt to Equity Ratio | 0.0402 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | -0.02% |